| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
Department of Endocrinology, Hospital Ramon y Cajal, Madrid, Spain. mibarsd@infomed.es
Adiponectin, also called GBP-28, apM1, AdipoQ and Acrp30, is a novel adipose tIssue-specific protein that has structural homology to collagen VIII and X and complement factor C1q, and that circulates in human plasma at high levels. It is one of the physiologically active polypeptides secreted by adipose tIssue, whose multiple functions have started to be understood in the last few Years.A reduction in adiponectin expression is associated with insulin resistance in some animal models. Administration of adiponectin has been accompanied by a reduction in plasma glucose and an increase in insulin sensitivity. In addition, thiazolidinediones, drugs that enhance insulin sensitivity through stimulation of the peroxisome proliferator-activated receptor-gamma, increase plasma adiponectin and mRNA levels in mice. On the other hand, this adipocyte protein seems to play a protective role in experimental models of vascular injury. In humans, adiponectin levels are inversely related to the degree of adiposity and positively associated with insulin sensitivity both in healthy subjects and in diabetic patients. Plasma adiponectin levels have been reported to be decreased in some insulin-resistant states, such as obesity and type 2 diabetes mellitus, and also in patients with coronary artery disease. On the contrary, chronic renal failure, type 1 diabetes and anorexia nervosa are associated with increased plasma adiponectin levels. Concentrations of plasma adiponectin have been shown to correlate negatively with glucose, insulin, triglyceride levels and body mass index, and positively with high-density lipoprotein-cholesterol levels and insulin-stimulated glucose disposal. Weight loss and therapy with thiazolidinediones increased endogenous adiponectin production in humans.Adiponectin increases insulin sensitivity by increasing tIssue fat oxidation, resulting in reduced circulating fatty acid levels and reduced intracellular triglyceride contents in liver and muscle. This protein also suppresses the expression of adhesion molecules in vascular endothelial cells and cytokine production from macrophages, thus inhibiting the inflammatory processes that occur during the early phases of atherosclerosis. In view of these data, it is possible that hypoadiponectinemia may play a role in the development of atherosclerotic vascular disease.In summary, the ability of adiponectin to increase insulin sensitivity in conjunction with its anti-inflammatory and anti-atherogenic properties have made this novel adipocytokine a promising therapeutic tool for the future, with potential applications in states associated with low plasma adiponectin levels.
This article has been cited by other articles:
|
|
 |
|
  M. Kyriakakou, A. Malamitsi-Puchner, H. Militsi, T. Boutsikou, A. Margeli, D. Hassiakos, C. Kanaka-Gantenbein, I. Papassotiriou, and G. Mastorakos Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates, and their mothers Eur. J. Endocrinol., March 1, 2008; 158(3): 343 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sir-Petermann, M. Maliqueo, E. Codner, B. Echiburu, N. Crisosto, V. Perez, F. Perez-Bravo, and F. Cassorla Early Metabolic Derangements in Daughters of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4637 - 4642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Saito, D. Fujioka, K.-i. Kawabata, T. Kobayashi, T. Yano, T. Nakamura, Y. Kodama, H. Takano, Y. Kitta, J.-e. Obata, et al. Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-{alpha}-treated cardiomyocytes in association with improved glucose uptake Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3490 - H3497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Archanco, J. Gomez-Ambrosi, M. Tena-Sempere, G. Fruhbeck, and M. A. Burrell Expression of Leptin and Adiponectin in the Rat Oviduct J. Histochem. Cytochem., October 1, 2007; 55(10): 1027 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Maahs, L. G. Ogden, J. K. Snell-Bergeon, G. L. Kinney, R. P. Wadwa, J. E. Hokanson, D. Dabelea, A. Kretowski, R. H. Eckel, and M. Rewers Determinants of Serum Adiponectin in Persons with and without Type 1 Diabetes Am. J. Epidemiol., September 15, 2007; 166(6): 731 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Barb, C. J Williams, A. K Neuwirth, and C. S Mantzoros Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 858S - 866S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sir-Petermann, B. Echiburu, M M. Maliqueo, N. Crisosto, F. Sanchez, C. Hitschfeld, M. Carcamo, P. Amigo, and F. Perez-Bravo Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome Hum. Reprod., July 1, 2007; 22(7): 1830 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jurimae and T. Jurimae Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E42 - E47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Qatanani and M. A. Lazar Mechanisms of obesity-associated insulin resistance: many choices on the menu Genes & Dev., June 15, 2007; 21(12): 1443 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Santosa, I. Demonty, A. H. Lichtenstein, K. Cianflone, and P. J.H. Jones An Investigation of Hormone and Lipid Associations after Weight Loss in Women J. Am. Coll. Nutr., June 1, 2007; 26(3): 250 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Y. Bang, J. L. Saver, B. Ovbiagele, Y. J. Choi, S. R. Yoon, and K. H. Lee Adiponectin levels in patients with intracranial atherosclerosis Neurology, May 29, 2007; 68(22): 1931 - 1937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Wahba and R. H. Mak Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 550 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Friberg, C. S. Mantzoros, and A. Wolk Diabetes and Risk of Endometrial Cancer: A Population-Based Prospective Cohort Study Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 276 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Kraemer and V. D. Castracane Exercise and Humoral Mediators of Peripheral Energy Balance: Ghrelin and Adiponectin Experimental Biology and Medicine, February 1, 2007; 232(2): 184 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, M. D. Michael, S. Kash, W. R. Bensch, B. P. Monia, S. F. Murray, K. A. Otto, S. K. Syed, S. Bhanot, K. W. Sloop, et al. Deficiency of Adiponectin Receptor 2 Reduces Diet-Induced Insulin Resistance but Promotes Type 2 Diabetes Endocrinology, February 1, 2007; 148(2): 683 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. Yee, N. Williams, P. Wen, D. C. Young, J. Lester, M. V. Johnson, W. B. Farrar, M. J. Walker, S. P. Povoski, S. Suster, et al. Pilot Study of Rosiglitazone Therapy in Women with Breast Cancer: Effects of Short-term Therapy on Tumor Tissue and Serum Markers Clin. Cancer Res., January 1, 2007; 13(1): 246 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Friberg, C. S. Mantzoros, and A. Wolk Physical Activity and Risk of Endometrial Cancer: A Population-Based Prospective Cohort Study Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2136 - 2140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Ategbo, O. Grissa, A. Yessoufou, A. Hichami, K. L. Dramane, K. Moutairou, A. Miled, A. Grissa, M. Jerbi, Z. Tabka, et al. Modulation of Adipokines and Cytokines in Gestational Diabetes and Macrosomia J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4137 - 4143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Glintborg, M. Andersen, C. Hagen, J. Frystyk, V. Hulstrom, A. Flyvbjerg, and A. P. Hermann Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur. J. Endocrinol., August 1, 2006; 155(2): 337 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schaffler, U. Muller-Ladner, J. Scholmerich, and C. Buchler Role of Adipose Tissue as an Inflammatory Organ in Human Diseases Endocr. Rev., August 1, 2006; 27(5): 449 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bojesen, K. Kristensen, N. H. Birkebaek, J. Fedder, L. Mosekilde, P. Bennett, P. Laurberg, J. Frystyk, A. Flyvbjerg, J. S. Christiansen, et al. The Metabolic Syndrome Is Frequent in Klinefelter's Syndrome and Is Associated With Abdominal Obesity and Hypogonadism Diabetes Care, July 1, 2006; 29(7): 1591 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fujioka, K.-i. Kawabata, Y. Saito, T. Kobayashi, T. Nakamura, Y. Kodama, H. Takano, J.-e. Obata, Y. Kitta, K. Umetani, et al. Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2409 - H2416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. Kim, M. Kong, T. M. Kim, Y. H. Suh, W.-H. Kim, J. H. Lim, J. H. Song, and M. H. Jung NFATc4 and ATF3 Negatively Regulate Adiponectin Gene Expression in 3T3-L1 Adipocytes. Diabetes, May 1, 2006; 55(5): 1342 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Englund Ogge, G. Brohall, C. J. Behre, C. Schmidt, and B. Fagerberg Alcohol Consumption in Relation to Metabolic Regulation, Inflammation, and Adiponectin in 64-Year-Old Caucasian Women: A population-based study with a focus on impaired glucose regulation Diabetes Care, April 1, 2006; 29(4): 908 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ehling, A. Schaffler, H. Herfarth, I. H. Tarner, S. Anders, O. Distler, G. Paul, J. Distler, S. Gay, J. Scholmerich, et al. The Potential of Adiponectin in Driving Arthritis J. Immunol., April 1, 2006; 176(7): 4468 - 4478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pagano, G. Soardo, C. Pilon, C. Milocco, L. Basan, G. Milan, D. Donnini, D. Faggian, M. Mussap, M. Plebani, et al. Increased Serum Resistin in Nonalcoholic Fatty Liver Disease Is Related to Liver Disease Severity and Not to Insulin Resistance J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1081 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Qiao, J. Schaack, and J. Shao Suppression of Adiponectin Gene Expression by Histone Deacetylase Inhibitor Valproic Acid Endocrinology, February 1, 2006; 147(2): 865 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Knobler, M. Benderly, V. Boyko, S. Behar, Z. Matas, A. Rubinstein, I. Raz, and J. Wainstein Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose Eur. J. Endocrinol., January 1, 2006; 154(1): 87 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Greco, G. Latini, F. Chiarelli, P. Iannetti, and A. Verrotti Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid Neurology, December 13, 2005; 65(11): 1808 - 1809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X Fang, R Palanivel, X Zhou, Y Liu, A Xu, Y Wang, and G Sweeney Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts J. Mol. Endocrinol., December 1, 2005; 35(3): 465 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zitzmann, M. Erren, A. Kamischke, M. Simoni, and E. Nieschlag Endogenous Progesterone and the Exogenous Progestin Norethisterone Enanthate Are Associated with a Proinflammatory Profile in Healthy Men J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6603 - 6608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Wei, E. Giovannucci, C. S. Fuchs, W. C. Willett, and C. S. Mantzoros Low Plasma Adiponectin Levels and Risk of Colorectal Cancer in Men: A Prospective Study J Natl Cancer Inst, November 16, 2005; 97(22): 1688 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. G. Fatouros, S. Tournis, D. Leontsini, A. Z. Jamurtas, M. Sxina, P. Thomakos, M. Manousaki, I. Douroudos, K. Taxildaris, and A. Mitrakou Leptin and Adiponectin Responses in Overweight Inactive Elderly following Resistance Training and Detraining Are Intensity Related J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5970 - 5977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bobbert, H. Rochlitz, U. Wegewitz, S. Akpulat, K. Mai, M. O. Weickert, M. Mohlig, A. F.H. Pfeiffer, and J. Spranger Changes of Adiponectin Oligomer Composition by Moderate Weight Reduction Diabetes, September 1, 2005; 54(9): 2712 - 2719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Efstathiou, D. I. Tsioulos, A. G. Tsiakou, Y. E. Gratsias, A. V. Pefanis, and T. D. Mountokalakis Plasma Adiponectin Levels and Five-Year Survival After First-Ever Ischemic Stroke Stroke, September 1, 2005; 36(9): 1915 - 1919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hamerman Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies QJM, July 1, 2005; 98(7): 467 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pagano, O. Marin, A. Calcagno, P. Schiappelli, C. Pilon, G. Milan, M. Bertelli, E. Fanin, G. Andrighetto, G. Federspil, et al. Increased Serum Resistin in Adults with Prader-Willi Syndrome Is Related to Obesity and Not to Insulin Resistance J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4335 - 4340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Schaffler and H Herfarth Creeping fat in Crohn's disease: travelling in a creeper lane of research? Gut, June 1, 2005; 54(6): 742 - 744. [Full Text] [PDF]
|
|
|
|
|
|
L. Qiao, P. S. MacLean, J. Schaack, D. J. Orlicky, C. Darimont, M. Pagliassotti, J. E. Friedman, and J. Shao C/EBP{alpha} Regulates Human Adiponectin Gene Transcription Through an Intronic Enhancer Diabetes, June 1, 2005; 54(6): 1744 - 1754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Satoh, M.T. A. Nguyen, M. Trujillo, T. Imamura, I. Usui, P. E. Scherer, and J. M. Olefsky Adenovirus-Mediated Adiponectin Expression Augments Skeletal Muscle Insulin Sensitivity in Male Wistar Rats Diabetes, May 1, 2005; 54(5): 1304 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Tanko, Y. Z. Bagger, G. Qin, P. Alexandersen, P. J. Larsen, and C. Christiansen Enlarged Waist Combined With Elevated Triglycerides Is a Strong Predictor of Accelerated Atherogenesis and Related Cardiovascular Mortality in Postmenopausal Women Circulation, April 19, 2005; 111(15): 1883 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Maahs, L. G. Ogden, G. L. Kinney, P. Wadwa, J. K. Snell-Bergeon, D. Dabelea, J. E. Hokanson, J. Ehrlich, R. H. Eckel, and M. Rewers Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification Circulation, February 15, 2005; 111(6): 747 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A M Diehl, Z P Li, H Z Lin, and S Q Yang Cytokines and the pathogenesis of non-alcoholic steatohepatitis Gut, February 1, 2005; 54(2): 303 - 306. [Full Text] [PDF]
|
|
|
|
|
|
M. Ishikawa, J. Kitayama, S. Kazama, T. Hiramatsu, K. Hatano, and H. Nagawa Plasma Adiponectin and Gastric Cancer Clin. Cancer Res., January 15, 2005; 11(2): 466 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J Wilkin and L. D Voss Metabolic syndrome: maladaptation to a modern world J R Soc Med, November 1, 2004; 97(11): 511 - 520. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zoico, V. Di Francesco, G. Mazzali, R. Vettor, F. Fantin, L. Bissoli, S. Guariento, O. Bosello, and M. Zamboni Adipocytokines, Fat Distribution, and Insulin Resistance in Elderly Men and Women J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2004; 59(9): M935 - M939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ueno, M. G. Dube, A. Inui, P. S. Kalra, and S. P. Kalra Leptin Modulates Orexigenic Effects of Ghrelin and Attenuates Adiponectin and Insulin Levels and Selectively the Dark-Phase Feeding as Revealed by Central Leptin Gene Therapy Endocrinology, September 1, 2004; 145(9): 4176 - 4184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Reinehr, C. Roth, T. Menke, and W. Andler Adiponectin before and after Weight Loss in Obese Children J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3790 - 3794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Panidis, A. Kourtis, A. Kukuvitis, D. Farmakiotis, N. Xita, I. Georgiou, and A. Tsatsoulis Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of {Delta}4-androstenedione Hum. Reprod., August 1, 2004; 19(8): 1728 - 1733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. J. F. Tietge, K. H. W. Boker, M. P. Manns, and M. J. Bahr Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E82 - E89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Kershaw and J. S. Flier Adipose Tissue as an Endocrine Organ J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2548 - 2556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Gale, V. D. Castracane, and C. S. Mantzoros Energy Homeostasis, Obesity and Eating Disorders: Recent Advances in Endocrinology J. Nutr., February 1, 2004; 134(2): 295 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, P. W. Connelly, S. B. Harris, and B. Zinman Adiponectin in a Native Canadian Population Experiencing Rapid Epidemiological Transition Diabetes Care, December 1, 2003; 26(12): 3219 - 3225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, and M. J. Quon Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells J. Biol. Chem., November 7, 2003; 278(45): 45021 - 45026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Lihn, B. Richelsen, S. B. Pedersen, S. B. Haugaard, G. S. Rathje, S. Madsbad, and O. Andersen Increased expression of TNF-{alpha}, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1072 - E1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Ramsay, N. Jamieson, I. A. Greer, and N. Sattar Paradoxical Elevation in Adiponectin Concentrations in Women With Preeclampsia Hypertension, November 1, 2003; 42(5): 891 - 894. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
